ProShare Advisors’s Cartesian Therapeutics RNAC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-683
| Closed | -$13.3K | – | 1974 |
|
|
2024
Q1 | $13.3K | Buy |
683
+35
| +5% | +$682 | ﹤0.01% | 1988 |
|
|
2023
Q4 | $13.4K | Sell |
648
-189
| -23% | -$3.91K | ﹤0.01% | 1939 |
|
|
2023
Q3 | $26.6K | Buy |
837
+3
| +0.4% | +$95 | ﹤0.01% | 1767 |
|
|
2023
Q2 | $28K | Buy |
834
+480
| +136% | +$16.1K | ﹤0.01% | 1819 |
|
|
2023
Q1 | $14.7K | Sell |
354
-68
| -16% | -$2.83K | ﹤0.01% | 1748 |
|
|
2022
Q4 | $14.3K | Sell |
422
-6
| -1% | -$203 | ﹤0.01% | 1819 |
|
|
2022
Q3 | $21K | Buy |
428
+34
| +9% | +$1.67K | ﹤0.01% | 1713 |
|
|
2022
Q2 | $15K | Sell |
394
-584
| -60% | -$22.2K | ﹤0.01% | 1780 |
|
|
2022
Q1 | $36K | Sell |
978
-240
| -20% | -$8.83K | ﹤0.01% | 2139 |
|
|
2021
Q4 | $119K | Buy |
1,218
+11
| +0.9% | +$1.08K | ﹤0.01% | 2167 |
|
|
2021
Q3 | $151K | Sell |
1,207
-243
| -17% | -$30.4K | ﹤0.01% | 1847 |
|
|
2021
Q2 | $182K | Buy |
1,450
+348
| +32% | +$43.7K | ﹤0.01% | 2168 |
|
|
2021
Q1 | $150K | Buy |
1,102
+45
| +4% | +$6.13K | ﹤0.01% | 2105 |
|
|
2020
Q4 | $96K | Buy |
+1,057
| New | +$96K | ﹤0.01% | 1995 |
|